Literature DB >> 33186508

Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial.

Chi Young Shim1, Jiwon Seo1, Iksung Cho1, Chan Joo Lee1, In-Jeong Cho2, Purevjargal Lhagvasuren3, Seok-Min Kang1, Jong-Won Ha1, Gyoonhee Han4, Yangsoo Jang1, Geu-Ru Hong1.   

Abstract

Entities:  

Keywords:  diabetes mellitus; diastole; echocardiography, stress; function; sodium-glucose transporter 2 inhibitors

Mesh：

Substances：

Year:  2020        PMID： 33186508     DOI： 10.1161/CIRCULATIONAHA.120.051992

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

Review 1.  Effects of SGLT2 inhibitors on cardiac structure and function.

Authors:  Giuseppina Novo; Tommaso Guarino; Daniela Di Lisi; Paolo Biagioli; Erberto Carluccio
Journal:  Heart Fail Rev       Date:  2022-06-16       Impact factor: 4.214

Review 2.  Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling.

Authors:  Husam M Salah; Subodh Verma; Carlos G Santos-Gallego; Ankeet S Bhatt; Muthiah Vaduganathan; Muhammad Shahzeb Khan; Renato D Lopes; Subhi J Al'Aref; Darren K McGuire; Marat Fudim
Journal:  J Cardiovasc Transl Res       Date:  2022-03-15       Impact factor: 4.132

3.  Genetic Determinants of Body Mass Index and Fasting Glucose Are Mediators of Grade 1 Diastolic Dysfunction.

Authors:  Nataraja Sarma Vaitinadin; Mingjian Shi; Christian M Shaffer; Eric Farber-Eger; Brandon D Lowery; Vineet Agrawal; Deepak K Gupta; Dan M Roden; Quinn S Wells; Jonathan D Mosley
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

Review 4.  The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence.

Authors:  Manasvi Gupta; Shiavax Rao; Gaurav Manek; Gregg C Fonarow; Raktim K Ghosh
Journal:  Ther Clin Risk Manag       Date:  2021-08-12       Impact factor: 2.755

5.  Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.

Authors:  Archana Rai; Kim A Connelly; Subodh Verma; C David Mazer; Hwee Teoh; Ming-Yen Ng; Idan Roifman; Adrian Quan; Marina Pourafkari; Laura Jimenez-Juan; Venkat Ramanan; Yin Ge; Djeven P Deva; Andrew T Yan
Journal:  Acta Diabetol       Date:  2022-01-21       Impact factor: 4.280

Review 6.  New antidiabetic therapy and HFpEF: light at the end of tunnel?

Authors:  Marijana Tadic; Carla Sala; Sahrai Saeed; Guido Grassi; Giuseppe Mancia; Wolfang Rottbauer; Cesare Cuspidi
Journal:  Heart Fail Rev       Date:  2021-04-11       Impact factor: 4.654

Review 7.  Effect of sodium-glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis.

Authors:  Yi-Wen Yu; Xue-Mei Zhao; Yun-Hong Wang; Qiong Zhou; Yan Huang; Mei Zhai; Jian Zhang
Journal:  Cardiovasc Diabetol       Date:  2021-01-25       Impact factor: 9.951

8.  Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study.

Authors:  Sergio Gamaza-Chulián; Enrique Díaz-Retamino; Fátima González-Testón; José Carlos Gaitero; María José Castillo; Raquel Alfaro; Elías Rodríguez; Eva González-Caballero; Antonio Martín-Santana
Journal:  BMC Cardiovasc Disord       Date:  2021-09-21       Impact factor: 2.298

9.  Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial.

Authors:  Scott D Solomon; Rudolf A de Boer; David DeMets; Adrian F Hernandez; Silvio E Inzucchi; Mikhail N Kosiborod; Carolyn S P Lam; Felipe Martinez; Sanjiv J Shah; Daniel Lindholm; Ulrica Wilderäng; Fredrik Öhrn; Brian Claggett; Anna Maria Langkilde; Magnus Petersson; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2021-06-09       Impact factor: 15.534

Review 10.  SGLT2 Inhibitors and Their Mode of Action in Heart Failure-Has the Mystery Been Unravelled?

Authors:  Steffen Pabel; Nazha Hamdani; Mark Luedde; Samuel Sossalla
Journal:  Curr Heart Fail Rep       Date:  2021-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.